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xysterol binding proteins (OSBPs) comprise a large
conserved family of proteins in eukaryotes. Their
ubiquity notwithstanding, the functional activities
of these proteins remain unknown. Kes1p, one of seven
members of the yeast OSBP family, negatively regulates
Golgi complex secretory functions that are dependent on
the action of the major yeast phosphatidylinositol/phos-
phatidylcholine Sec14p. We now demonstrate that Kes1p
is a peripheral membrane protein of the yeast Golgi com-
plex, that localization to the Golgi complex is required for
O
 
Kes1p function in vivo, and that targeting of Kes1p to the
Golgi complex requires binding to a phosphoinositide pool
generated via the action of the Pik1p, but not the Stt4p, PtdIns
4-kinase. Localization of Kes1p to yeast Golgi region also
requires function of a conserved motif found in all members
of the OSBP family. Finally, we present evidence to suggest
that Kes1p may regulate adenosine diphosphate-ribosylation
factor (ARF) function in yeast, and that it may be through
altered regulation of ARF that Kes1p interfaces with Sec14p
in controlling Golgi region secretory function.
 
Introduction
 
Oxysterol binding proteins (OSBPs)* define a large protein
family whose members are found in mammals (Dawson et
al., 1989), 
 
Drosophila
 
 (Alphey et al., 1998), 
 
C. elegans
 
(
 
Caenorhabditis elegans
 
 Sequencing Consortium, 1998), and
yeast (Jiang et al., 1994; Fang et al., 1996; Beh et al., 2001).
Initial studies suggested that OSBPs mediate the potent
downregulation of sterol biosynthesis by oxysterols (Taylor et
al., 1984; Dawson et al., 1989). Although evidence consistent
with this hypothesis was culled from genetic experiments in
yeast and mammalian cells (Jiang et al., 1994; Lagace et al.,
1997; Beh et al., 2001), other evidence indicates that OSBPs
are not direct mediators of oxysterol signaling (Brown and
Goldstein, 1999). Rather, these proteins have other func-
tions that interface with membrane trafficking from the
Golgi complex (Fang et al., 1996), progression of cells
through the cell cycle (Alphey et al., 1998), and tumor me-
tastasis (Fournier et al., 1999).
Yeast express seven OSBPs. Three (Osh1p, Osh2p, and
Osh3p) are classified as long OSBPs, typified by the
mammalian OXYB, where a large extension is found NH
 
2
 
-
terminal to the 430 amino acid oxysterol binding homology
domain (Fig. 1 A). The remaining four are homologous to
the oxysterol binding domain of OXYB and are classified as
short OSBPs (Fig. 1 A). None of the yeast OSBPs individually
plays an essential function, but deletion of all seven OSBP
genes results in inviability (Jiang et al., 1994; Fang et al.,
1996; Levine and Munro, 1998; Beh et al., 2001).
Sec14p is the major yeast PI/PC-transfer protein (PITP)
(Bankaitis et al., 1990; Kearns et al., 1998a; Li et al., 2000b).
Analyses of mutations that allow yeast to grow in the absence
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of the essential Sec14p (i.e., ‘bypass Sec14p’ mutations) dem-
onstrate that Sec14p regulates lipid metabolism so that a per-
missive membrane environment for Golgi complex secretory
function is maintained (Fig. 1 B; Cleves et al., 1991a,b; Mc-
Gee et al., 1994; Huijbregts et al., 2000; Li et al., 2000b; Xie
et al., 2001). An important component of this Sec14p-medi-
ated regulation of lipid metabolism appears to involve stimula-
tion of the adenosine diphosphate-ribosylation factor gua-
nosine triphosphatase activating protein (ARFGAP) activities
of the yeast 
 
GCS1
 
 and 
 
AGE2
 
 gene products (Yanagisawa, L.,
and V.A. Bankaitus, unpublished data). In this fashion,
Sec14p may impose a trans-Golgi region–specific regulation of
the adenosine diphosphate-ribosylation factor (ARF) GTPase
cycle in yeast. A functional relationship between Sec14p and
OSBP function in yeast became apparent when it was discov-
ered that inactivation of the 
 
KES1
 
 gene, which encodes one of
the short OSBP family members, uniquely elicits a “bypass
Sec14p” phenotype (Fang et al., 1996). No other individual
yeast OSBP defect elicits “bypass Sec14p” (Fang et al., 1996;
Beh et al., 2001). This “bypass Sec14p” phenotype makes it
possible to dissect the various functional properties of Kes1p.
Herein, we demonstrate that yeast Kes1p is a phosphoi-
nositide
 
 
 
(PIP) binding protein whose lipid binding activities
are necessary, but not sufficient, for Kes1p localization to
yeast Golgi membranes. We also show that Golgi complex
localization is critical for Kes1p function. Finally, we present
evidence to suggest that Kes1p activity influences ARF func-
tion in yeast. The collective data suggest that OSBPs are
compartment specific regulators (or effectors) of ARF func-
tion in eukaryotes.
 
Results
 
Kes1p functional domains
 
We independently recovered 51 
 
kes1
 
 loss-of-function muta-
tions in a “bypass Sec14p” mutant screen (Cleves et al.,
1991b; Fang et al., 1996). Of these, nine sustain wild-type
levels of Kes1p. Gap repair experiments, coupled with DNA
sequence determinations, revealed these nine mutations de-
fine six alleles (Fig. 2 A). Four represent a GAA 
 
→ 
 
AA mu-
tation that substitutes lysine for glutamate at Kes1p residue
312 (E312K). One represents a double mutation that con-
verts codons 201 and 202 from TTGCAT to TTCAAT,
and substitutes phenylalanine-asparagine for leucine-histi-
dine (LH20/202FN).
The sequences surrounding P30T, S43Y, and LH201/
202FN revealed no informative homologies. However, clues
were gleaned from regions surrounding the E312K, E107K,
and K109A substitutions. E312K lies within a domain that
exhibits features of Pleckstrin homology (PH) domains. Al-
though this region is not scored as a PH domain by various
search programs, it includes the signature invariant tryp-
tophan (W317) that is positioned 
 
 
 
100 residues down-
stream of a GIL motif (Kes1p residues 205–207). PH do-
mains are often bounded by a GXL motif at the NH
 
2
 
terminus, and the signature tryptophan is positioned 
 
 
 
110
residues downstream of that motif (Lemmon, 1999). Align-
ment of the putative Kes1p PH domain (residues 180–330)
with known PH domains is shown (Fig. 2 B). Although
proof that this domain conforms to the PH domain fold
awaits structural analyses, for purposes of convenience we
will refer to this domain as the Kes1p PH domain.
BLAST analyses also identify a motif (Kes1p residues
108–149) that is present only in OSBPs and is highly con-
served among them (Fig. 2 C). This OSBP domain consists
of two 11-residue motifs separated by a linker of 
 
 
 
20 diver-
gent residues. Two of the 
 
kes1
 
 alleles alter residues adjacent
to (E107K), or within (H143Y), this domain.
 
Kes1p is a PIP binding protein
 
As PI(4,5)P
 
2
 
 and other PIPs are common ligands for PH
domains, we assessed binding of purified Kes1p to
Figure 1. Kes1p function and the Sec14p pathway. (A) The yeast 
OSBP family. The general organization of the seven yeast OSBP 
family members is given and compared with the human OSBP 
(hOSBP). Yeast proteins are identified at left by their common designations (see Beh et al., 2001). Regions homologous to the oxysterol bind-
ing domain of hOSBP are shown in black, and the primary sequence identities within that region are given. The three long yeast OSBPs 
(Osh1p, Osh2p and Osh3p) share homologies at their COOH-terminal domains with hOSBP (stippled areas), whereas these particular homol-
ogies are present in the four short yeast OSBPs (Kes1p, Hes1p, Osh6, and Osh7). Ultimate residues for each protein are numbered at right. (B) 
Pathway for Sec14p-dependent Golgi secretory function. Roles for phosphatidylcholine (PC), DAG, PA, PI(4)P, and PI(4,5)P2 in stimulating 
yeast Golgi complex secretory function have been proposed. PC, DAG, and PA are proposed to mediate combinatorial regulation of a pair of 
imperfectly redundant ARFGAPs (Gcs1p and Age2p) whose activity is required for Sec14p pathway function (Yanagisawa, L., and V.A. Ban-
kaitus, unpublished data). The known execution points for relevant genes whose inactivation effects “bypass Sec14p” (i.e., CKI1, PCT1, 
CPT1, and SAC1) are shown. The execution point of the KES1 gene product in the Sec14p pathway is unknown. 
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PI(4,5)P
 
2
 
 or its soluble headgroup inositol-1,4,5-trispho-
sphate (IP
 
3
 
). To this end, [
 
3
 
H]-BZDC-PI(4,5)P
 
2
 
 and
[
 
3
 
H]-BZDC-IP
 
3
 
 were used as photo-affinity ligands
(Dorman and Prestwich, 1994; Prestwich, 1996; Prest-
wich et al., 1997; Chaudhary et al., 1998a,b; Feng et al.,
2001). The [
 
3
 
H]-BZDC-PI(4,5)P
 
2
 
 binding experiments
were performed in a mixed micelle system where the
photo-affinity ligand was a trace component. Thus, the
photolabeling assay requires Kes1p to interact with photo
probe monomers in the face of large detergent excess. Al-
though Sec14p fails to bind either probe (unpublished
data), Kes1p binds both [
 
3
 
H]-BZDC-PI(4,5)P
 
2
 
 and [
 
3
 
H]-
BZDC-IP
 
3
 
 avidly, as indicated by recovery of appropriate
covalent adducts (Fig. 3 A). The intensities of Kes1p
photolabeling were similar to those scored for the PIP
binding protein gelsolin.
Kes1p-[
 
3
 
H]-BZDC-IP
 
3
 
 solution binding experiments also
impose rigorous constraints on binding. Both photo-probes
are displaced from Kes1p by challenge with excess unlabeled
PI(4,5)P
 
2
 
 or IP
 
3
 
 competitor. However, an 83-fold molar ex-
cess of unlabeled PI(4,5)P
 
2
 
 displaces both photo-probes,
whereas a 10
 
3
 
-fold molar excess of IP
 
3
 
 is required for dis-
placement of [
 
3
 
H]-BZDC-PI(4,5)P
 
2
 
 (Fig. 3 A). These data
suggest that Kes1p has a 10-fold higher affinity for PI(4,5)P
 
2
 
than it does for IP
 
3
 
.
To quantify Kes1p affinity for PI(4,5)P
 
2
 
, we deter-
mined the concentration of competitor required for 50%
displacement of [
 
3
 
H]BZDC-PI(4,5)P
 
2
 
 from Kes1p (IC
 
50
 
).
Although photoaffinity labeling is a nonequilibrium pro-
cess (Dorman and Prestwich, 1994) and cannot directly
give equilibrium dissociation constants, displacement by
competing ligands yields a rank order of relative affini-
ties. A dose-dependent reduction in photolabeling effi-
ciency was observed when PI(4,5)P
 
2
 
 was employed as
competitor (Fig. 3 B). The IC
 
50
 
 for PI(4,5)P
 
2
 
 is 1.9 
 
 
 
M
with an estimated 
 
K
 
D
 
 
 
 
 
 2.5 
 
 
 
M for Kes1p-[
 
3
 
H]BZDC-
PI(4,5)P
 
2
 
 binding. These values resemble those measured
for PI(4,5)P
 
2
 
 and [
 
3
 
H]BZDC-PI(4,5)P
 
2
 
 binding by PLC-
 
 
 
1 (Tall et al., 1997; Lemmon, 1999).
 
Kes1p PH domain is sufficient for PIP binding
 
We tested whether the Kes1p PH domain represents the
PI(4,5)P
 
2
 
 and IP
 
3
 
 binding module. Indeed, a 144 amino
acid Kes1p fragment that consists largely of the PH do-
main (residues 171–314) is sufficient for PI(4,5)P
 
2
 
 and IP
 
3
 
binding (Fig. 3 C). A 110 amino acid region of Kes1p (res-
idues 205–314) that defines the putative Kes1p PH do-
main (Fig. 2 B) also binds IP
 
3
 
 photo-probe (unpublished
data). Neither a smaller region of Kes1p (residues 205–
309) that fully overlaps this domain, nor a Kes1p domain
(residues 220–330) that incompletely overlaps this domain
exhibits any inositide binding activity (unpublished data).
Interestingly, the minimum Kes1p inositide binding mod-
ule does not include W317, the signature residue of PH
domains (Fig. 2 B; see below).
 
Specificity of PIP binding
 
To characterize specificity of Kes1p binding to PIPs, we
employed a competitive displacement strategy using a
variety of binding substrates in a Kes1p-[
 
3
 
H]BZDC-
PI(4,5)P
 
2
 
 photolabeling assay. At 400-fold molar excess,
all PIPs tested and other acidic phospholipids (phosphati-
dylserine, phosphatidic acid, and cardiolipin) displaced
[
 
3
 
H]BZDC-PI(4,5)P
 
2
 
 (Fig. 3 D). Other lipids (phos-
phatidylethanolamine, phosphatidylcholine, ceramide, and
diacylglycerol) were ineffective. Soluble inositol-polyphos-
phates (IP
 
3
 
, IP
 
4
 
, IP
 
6
 
) also failed to displace [
 
3
 
H]BZDC-
PI(4,5)P
 
2
 
 from Kes1p (unpublished data). When unla-
beled competitor lipids were reduced to a 10-fold molar
excess relative to [
 
3
 
H]BZDC-PI(4,5)P
 
2
 
, only PI(4,5)P
 
2
 
displaced photo-probe. PI, PI(4)P, phosphatidic acid
(PA), and other acidic phospholipids were ineffective (un-
published data). A 10-fold molar excess of PI(3,4,5)P
 
3
 
,
PI(3,4)P
 
2
 
, or PI(3,5)P
 
2
 
 also failed to displace [
 
3
 
H]BZDC-
Figure 2. Kes1p functional domains. (A) Kes1p 
domain structure. The 434-residue Kes1p sequence 
is represented with the OSBP and PH domains 
identified by stippled boxes as indicated at top. 
The six kes1 inactivating mutations of interest are identified at bottom, and the individual sites of missense substitution relative to the Kes1p 
primary sequence representation are indicated by the black lines. (B) Kes1p PH domain. The primary sequence of the Kes1p PH domain is 
aligned other known PH domains (from Lemmon, 1999). A secondary structure diagram derived from the PLC- 1 PH domain crystal structure 
is given at top. The signature tryptophan of PH domains is boxed (W317 for Kes1p). Basic residues (i.e., R236, K242, and K243) in the predicted 
variable loop 2 (VL-2) of Kes1p that likely form the inositide binding motif are identified (solid circles). (C) OSBP domains from the yeast 
OSBPs and hOSBP are aligned. The canonical OSBP domain consists of two conserved motifs (identified by black bars at top) separated by 
linkers of 13–20 amino acids. 
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PI(4,5)P
 
2
 
 (Fig. 3 D). Thus, PI(4,5)P
 
2
 
 is the preferred
Kes1p ligand in vitro.
 
Mutations in the Kes1p PH domain influence PIP binding
 
Since the Kes1p PH domain binds PI(4,5)P
 
2
 
, we investi-
gated whether integrity of this domain is required for PIP
binding. To this end, we characterized the binding proper-
ties of Kes1p
 
E312K
 
 and Kes1p W317A (Kes1p
 
W317A
 
) using
the photolabeling assay described above. In neither case
could we detect binding of full-length mutant protein to
[
 
3
 
H]BZDC-PI(4,5)P
 
2
 
 (Fig. 4 A) or to [
 
3
 
H]BZDC-IP
 
3
 
 (un-
published data). In vivo complementation experiments re-
veal that Kes1p
 
E312K
 
 and Kes1p
 
W317A
 
, while stable proteins in
yeast, are nonfunctional (unpublished data).
 
Suppression of PIP binding defects by COOH-terminal 
truncation of Kes1p
During the course of the photolabeling experiments, we
noted that Kes1p
W317A purifies as two species. Both spe-
cies bind polyclonal anti-Kes1p immunoglobulin, suggest-
ing that the smaller species represents a Kes1p fragment.
Surprisingly, this truncated Kes1p (Kes1p
W317A*) binds
PI(4,5)P2, whereas full-length Kes1p
W317A does not (Fig. 4
A). Thus, removal of COOH-terminal Kes1p sequences res-
cues PIP binding by Kes1p
W317A. Although Kes1p
W317A was
most prominent in exhibiting this degradation product,
preparations of wild-type Kes1p also contain detectable
amounts of such a degradation product. This fragment also
retains PI(4,5)P2 binding capability (unpublished data).
Figure 3. Kes1p binds PIPs. (A) Photo-cross-linking of Kes1p to 
[
3H]BZDC-PI(4,5)P2 and [
3H]BZDC-IP3. Purified recombinant Kes1p 
was incubated with [
3H]BZDC-PI(4,5)P2 photo-probe in a mixed 
micelle system, the reaction was irradiated under long wave UV 
light, and covalent adducts were resolved by SDS-PAGE and 
autoradiography. In the left panels, a representative autoradiogram 
is shown with a corresponding densitometric quantification of 
photo-cross-linking provided below. A reaction of Kes1p and 
[
3H]BZDC-PI(4,5)P2 with no competitor yields the total photolabel-
ing lane (T). Addition of excess competitor PI(4,5)P2 (10  M) or 0.1 mM or 1 mM IP3, as indicated in the competition (C) lanes, displaces 
photo-probe from Kes1p and reduces photolabeling. In the right panel, a representative autoradiogram is shown from a Kes1p/[
3H]BZDC-IP3 
photolabeling reaction with no competitor IP3 (T) or with excess competitor IP3 (C). Purified gelsolin (gift from Paul Janmey, Harvard Medical 
School, Cambridge, MA) was employed as a positive control. Purified Sec14p fails to bind photo-probe and served as negative control 
(unpublished data). (B) Concentration-dependent displacement of photo-probe from Kes1p by PI(4,5)P2. Purified Kes1p was incubated in a 
series of mixed micelle photolabeling reactions supplemented with increasing concentrations of PI(4,5)P2. Efficiency of photolabeling was 
determined by densitometric scanning of autoradiograms, and is plotted as a function of the log10 of the competitor PI(4,5)P2 concentration. 
(C) Kes1p PH domain is sufficient for PIP binding. Purified recombinant Kes1p and Kes1p PH domain were incorporated into reactions using 
[
3H]BZDC-PI(4,5)P2 as photo-probe. Total (T) and competition (C) reactions are as above. (D) Kes1p has weak affinity for other acidic phospholipids. 
Kes1p was incorporated into a standard mixed micelle photolabeling reaction using [
3H]BZDC-PI(4,5)P2 as photo-probe. Reactions with no 
competitor (Total), and with competitor lipids (10  M final concentration; indicated at top), are shown. PIP, phosphatidylinositol-4-P; PI, 
phosphatidylinositol; PE; phosphatidylethanolamine; PS, phosphatidylserine; DiC8, di-C8:0 diacylglycerol.OSBPs and Sec14p function in yeast | Li et al. 67
Eleven cycles of Edman degradation indicate a sequence of
MRGSH6M for the Kes1p
W317A* NH2 terminus, and this se-
quence corresponds to the NH2-terminal sequence of the
His6-tagged Kes1p produced in Escherichia coli (see Materi-
als and methods). Consequently, the proteolytic event that
generates Kes1p
W317A* must remove a COOH-terminal
Kes1p domain.
The site of Kes1p proteolysis that generates Kes1p
W317A*
was determined. Matrix-assisted laser ionization coupled
with time-of-flight mass analysis (MALDI-TOF) analyses
yield a mass of 50.663 kD for Kes1p and 36.838 kD for
Kes1p
W317A* (Fig. 4 B). These data assigned the Kes1p
W317A*
cleavage site to the amide bond of a dibasic motif comprised
of Kes1p residues R314 and K315, indicating that
Kes1p
W317A* is devoid of the COOH-terminal 120 residues
(Fig. 4 B). Interestingly, this cleavage site lies upstream of
the W317A substitution. Thus, Kes1p
W317A* represents a
proteolytic fragment consisting solely of wild-type Kes1p
primary sequence.
To confirm this result, we purified GST-tagged versions
of full-length Kes1p and of a protein fragment generated by
engineering a Kes1p truncation immediately following resi-
due R314. This truncation product is designated Kes1p(1–
314). Consistent with the Kes1p
W317A* data, Kes1p(1–314)
Figure 4. Kes1p PH domain mutations and PIP binding. (A) 
Mutations in Kes1p PH domain compromise PIP binding. Photoaffinity-
labeling assays were performed with mutant Kes1ps using 
[
3H]BZDC-PI(4,5)P2 as photo-probe. Covalent Kes1p–photo-probe adducts were resolved by SDS-PAGE and visualized by autoradiography. 
Kes1p
E312K and full-length Kes1p
W317A fail to bind [
3H]BZDC-PI(4,5)P2. A proteolytic breakdown product of Kes1p
W317A (Kes1p
W317A*) regains 
PIP binding competence. (B) MALDI-TOF mass spectrometry of Kes1p
W317A and Kes1p
W317A*. The mass to charge ratios of full-length Kes1p
W317A 
and the Kes1p
W317A* truncation product are shown and the corresponding mass values for each are indicated. Below is an illustration of the 
Kes1p domain structure where the OSBP and PH domains are designated by the black and gray boxes, respectively. The location of the 
W317A missense substitution within the PH domain is shown by a black bar, and the surrounding wild-type sequence is displayed at bottom 
(W corresponds to W317). The R314K315 motif that defines the site of proteolysis that generates Kes1p
W317A* is underlined. (C) COOH-terminal 
Kes1p truncation and PIP binding. Wild-type and mutant forms of Kes1p were genetically truncated after residue K314 to generate protein 
fragments consisting of otherwise wild-type primary sequence (Kes1p
1–314). GST-tagged versions of Kes1p
1–314 and Kes1p
E312K* were purified 
and photolabeled with [
3H]BZDC-IP3 in a mixed micelle system in the absence (T) or presence (C) of competitor PI(4,5)P2. Both full-length 
protein and fragments associate with [
3H]BZDC-IP3 in a manner that is subject to displacement by PI(4,5)P2. (D) COOH-terminal truncation 
of Kes1p
3E fails to rescue PIP binding. GST-tagged Kes1p and Kes1p
3E, and the corresponding COOH-terminal truncation fragments Kes1p
1–314 
and Kes1p
3E* were purified were photolabeled with [
3H]BZDC-IP3 in a mixed micelle system without (T) and with (C) unlabeled PI(4,5)P2 
competitor. Full-length Kes1p
3E fails to bind photo-probe, and this failure is not rescued by Kes1p truncation. (E) PIP binding is essential for 
Kes1p function in vivo. Centromeric plasmids (YCp) that drive physiological levels of KES1 or kes1
3E expression were transformed into the 
kes1 strain CTY159. Transformants were streaked for isolation onto selective minimal media and incubated for 3 d at 26 C or 37 C. 
Complementation of kes1 defects is scored by failure of transformants to grow at 37 C.68 The Journal of Cell Biology | Volume 157, Number 1, 2002
binds [
3H]BZDC-IP3 with an affinity that is similar to that
exhibited by Kes1p itself (Fig. 4 C). We also tested whether
the COOH-terminal truncation restores PIP binding to the
mutant Kes1p
E312K. This experiment was of interest for two
reasons. First, it tests the allele specificity of the suppression
effect elicited by the COOH-terminal truncation mutation.
Second, because E312K is retained in the truncated product
(unlike the W317A case where the fragment consists of
wild-type Kes1p sequence), this experiment tests whether
E312K imposes an intrinsic PIP binding defect on Kes1p.
Photolabeling data demonstrated that Kes1p
E312K* binds
PIPs, whereas full-length Kes1p
E312K cannot (Fig. 4 C), indi-
cating deletion of the COOH-terminal 120 Kes1p residues
rescues both Kes1p
E312K and Kes1p
W317A PIP binding de-
fects. Thus, neither E312 nor W317 are intrinsically essen-
tial for PIP binding. Rather, COOH-terminal Kes1p se-
quences inhibit PIP binding by the Kes1p PH domain.
Kes1p mutants intrinsically defective in PIP binding
are nonfunctional
The data indicate that Kes1p
E312K and Kes1p
W317A exhibit
PIP binding defects of a regulatory nature. This complicates
conclusions that can be drawn regarding the significance of
PIP binding for Kes1p activity from functional analyses of
Kes1p
E312K and Kes1p
W317A alone. To more directly assess
the functional significance of PIP binding by Kes1p, we gen-
erated Kes1p derivatives with intrinsic defects in PIP bind-
ing. Our criteria for such mutants was that these will fail to
bind inositide photo-probe, and that these binding failures
will not be rescued by COOH-terminal Kes1p truncation.
To generate mutant Kes1p intrinsically defective in PIP
binding, we were guided by structural analyses indicating
that basic residues in the PH domain variable loop 1 and 2
regions engage inositide headgroups (Lemmon, 1999). We
generated a triple mutant Kes1p (Kes1p
3E) where residues
R236, K242, and K243 in the presumed loop 2 region of the
Kes1p PH domain were replaced with glutamate (see Fig. 2
B). Kes1p
3E fails to bind photo-probe in vitro, and trunca-
tion of Kes1p
3E distal to residue K314 fails to restore PIP
binding (Fig. 4 D). Thus, Kes1p
3E is intrinsically defective
in PIP binding.
The biochemical PIP binding defect translates to loss of
Kes1p activity in yeast. Complementation analyses demon-
strate that Kes1p
3E is nonfunctional in vivo (Fig. 4 D). This
defect is manifested even though Kes1p
3E is a stable cellular
protein that accumulates to steady-state levels that are sev-
eral-fold greater than those of wild-type Kes1p. Thus, PIP
binding is required for Kes1p function in vivo.
Kes1p OSBP domain is nonessential for PIP binding
To investigate the OSBP motif in detail, we performed ala-
nine-scanning mutagenesis throughout the OSBP domain
(Fig. 5 A). Complementation experiments show that
Kes1p
HH143/144AA, Kes1p
K109A, and Kes1p
E117A are nonfunc-
tional in vivo (Fig. 5 B), as are Kes1p
LG115/116AA and
Kes1p
EQ139/140AA. All of these proteins are expressed as sta-
ble polypeptides in cells (unpublished data). Thus, the
OSBP domain is critical for Kes1p function in yeast. Pho-
tolabeling experiments demonstrate that OSBP domain
mutants avidly bind photo-probe in a manner that is sub-
ject to competitive displacement by unlabeled PI(4,5)P2
competitor (Fig. 5 A). These data show that the OSBP do-
main is not required for PI(4,5)P2 binding as scored by the
photolabeling assay.
Other mutant forms of Kes1p (S43Y, E107K, LH201/
202FNo) harbor unadulterated PH and OSBP domains, yet
are nonfunctional in vivo (Fig. 2 A). We find that Kes1p
S43Y,
Kes1p
E107K, and Kes1p
LH201/202FN are all proficient in
[
3H]BZDC-PI(4,5)P2 binding. Moreover, bound photo-
probe is efficiently displaced by the incorporation of excess
unlabeled PI(4,5)P2 into the photolabeling assay (Fig. 5 C).
Competitive displacement assays using purified Kes1p
LH201/
202FN revealed an IC50 of photo-probe displacement of 6.1
 M when PI(4,5)P2 was employed as competitor (unpub-
lished data), a value that resembles the IC50 of 1.9  M re-
Figure 5. Analysis of Kes1p OSBP domain mutants. (A) OSBP 
domain is not required for PIP binding. The four missense substitutions, 
as underlined, were engineered into the Kes1p OSBP domain. Two 
representative proteins, Kes1p
K109A and Kes1p
HH143/144AA, were 
purified and employed in photolabeling assays using [
3H]BZDC-IP3 
as photo-probe. These mutant proteins, like Kes1p, retain PIP binding 
capability. (B) OSBP domain mutants are nonfunctional. Four low 
copy mutant plasmids were transformed into strain CTY159. Trans-
formants were restreaked onto appropriate media and grow for 2–3 d 
at 26 C or 37 C. Complementation was assessed as before. (C) PIP 
binding by Kes1p
S43Y, Kes1p
E107A, and Kes1p
LH201/202FN. The proteins 
were purified and photolabeled with [
3H]BZDC-IP3. These mutant 
proteins retain PIP binding capability.OSBPs and Sec14p function in yeast | Li et al. 69
corded for wild-type Kes1p (Fig. 3 B). Thus, these mutant
Kes1ps bind PI(4,5)P2 with affinities similar to that mea-
sured for Kes1p (KD   8.0  M vs. 2.5  M, respectively).
We conclude that PIP binding is necessary, but insufficient,
for Kes1p function in vivo.
Kes1p localizes to Golgi membranes
Fractionation studies revealed that Kes1p resides in both sol-
uble and membrane-bound pools (Fang et al., 1996). To lo-
calize Kes1p more precisely, a YCp(KES1-YFP) plasmid was
constructed that drives physiological expression levels of a
chimera consisting of Kes1p fused via its COOH terminus
to the green fluorescent protein (GFP) NH2 terminus. This
chimera is both stable and functional (unpublished data).
To assess Kes1p-GFP distribution, appropriate yeast strains
were cultured to midlogarithmic growth phase in minimal
medium at 26 C and cells were imaged. As control, we also
monitored localization of GFP expressed from an isogenic
YCp plasmid carrying a KES1 promoter cassette. Whereas
GFP is distributed diffusely throughout the cytosol, Kes1p-
GFP adopts both a diffuse cytosolic location and localization
to 3–10 punctate structures dispersed throughout the cyto-
plasm (Fig. 6).
The punctate component of Kes1p-GFP staining prima-
rily corresponds to a Golgi membrane–associated Kes1-GFP
pool. We observed that  85% of the Kes1-GFP–positive
structures costain with the yeast Golgi complex marker
Kex2p-RFP (Fig. 6). The remaining 15% of the Kes1-GFP–
positive structures costain with the fluorescent dye FM4-64
under conditions that trap this lipophilic molecule in early
endosomes.
Localization of Kes1p to Golgi membranes 
requires PIP binding
Previous reports had documented that PIP binding is
necessary and sufficient for localization of long OSBPs to
target membranes (Levine and Munro, 1998). To deter-
mine whether PIP binding plays the same role in target-
ing of short OSBPs, representative mutations in the
Kes1p PH domain were introduced into a YCp(KES1-
GFP) expression cassette. Localization of mutant Kes1-
GFP proteins was then monitored in living cells by fluo-
rescence microscopy.
As expected, the Kes1p
3E-GFP chimera exhibit a diffuse
intracellular distribution that contrasts with the punctate
Golgi region staining recorded for wild-type Kes1p-GFP
(Fig. 7 A). Thus, Kes1p
3E-GFP fails to localize to Golgi
membranes in vivo. We also assessed localization of
Kes1p
E312K and Kes1p
W317A. These species fail to bind PIPs
in vitro as full-length polypeptides, but regain PIP binding
activity when the COOH-terminal 120 Kes1p residues are
removed. Interestingly, Kes1p
E312K-GFP and Kes1p
W317A-
GFP exhibit localization profiles similar to those recorded
for wild-type Kes1p-GFP, suggesting Kes1p
E312K and
Kes1p
W317A target to Golgi membranes (Fig. 7 A). Thus, un-
like the PIP-binding defective Kes1p
3E, Kes1p
E312K and
Kes1p
W317A are apparently subject to regulatory compensa-
tion that exposes their PIP binding activities in the appropri-
ate in vivo context. Kes1p
E312K and Kes1p
W317A remain non-
functional, however.
Defects in PI-4-P synthesis compromise Kes1p 
localization to Golgi membranes
To test whether defects in PIP synthesis release of Kes1p from
Golgi membranes, we expressed Kes1p-GFP in strains carrying
ts alleles of each of the two known yeast phosphatidylinositol
(PI) 4-kinases (Pik1p and Stt4p). As described above, Kes1p-
GFP adopts a characteristic punctate localization pattern in
wild-type cells incubated at 26 C (Fig. 7 B). By contrast,
Kes1p-GFP redistributes from Golgi membranes to the cytosol
in the pik1-101
ts mutant incubated at either 26 C or 37 C (Fig.
7 B). Thus, Pik1p, which localizes to Golgi membranes
(Walch-Solimena and Novick, 1999), catalyzes synthesis of a
PIP pool, PI(4)P and/or PI(4,5)P2, that is required for localiza-
tion of Kes1p to yeast Golgi membranes. Kes1p mislocalization
in the pik1-101
ts strain at 26 C indicates that this pik1
ts allele is
quite defective even at permissive temperatures, a result in ac-
cord with the potent synthetic lethalities exhibited by pik1-101
ts
when combined with a number of other mutations that com-
promise secretory pathway function (Walch-Solimena and
Novick, 1999). By contrast, inactivation of Stt4p at 37 C re-
sults in some mislocalization of Kes1p to cytosol at 26 C (Fig. 7
B). Relative to pik1-101
ts, these effects are modest. Thus, Stt4p-
derived PIPs play more minor roles in Kes1p targeting to Golgi
Figure 6. Kes1p localization. YCp (KES1-YFP) and YEp (KEX2-RFP) 
plasmids were cotransformed into the kes1 yeast strain CTY159. 
Liquid cultures of the plasmid-bearing derivative strain were 
incubated overnight at 26 C with shaking in the appropriate minimal 
medium. The cultures were then diluted to OD600   0.2 0.3, and 
incubated for an additional 2 to 3 h at 26 C. Cells were gently 
pelleted and resuspended in  50  l residual medium, 5–8  l of the 
suspension was mounted onto glass slides, and the samples were 
visualized by fluorescence microscopy. The excitatory filters 
employed for visualization of GFP/YFP and RFP fluorescence were 
the quinacrine mustard filter (excitation wavelength 495 nm) and 
rhodamine filter (excitation wavelength 545 nm), respectively. 
Images were collected by IP Lab 2.0 software and processed 
with Adobe Photoshop
® 5.0. Arrows identify some examples 
of colocalization.70 The Journal of Cell Biology | Volume 157, Number 1, 2002
membranes than do Pik1p-derived PIPs. To distinguish
whether PI(4)P or PI(4,5)P2 is a Golgi region ligand for Kes1p,
we assessed Kes1p-GFP localization in mutants inactivated for
Mss4p, the yeast PI(4)P 5-kinase. Even long shift of mss4-2
ts
mutants to restrictive temperatures (37 C) fails to compromise
Kes1p-GFP association with Golgi membranes (Fig. 7 B).
We also tested whether inactivation of the Golgi complex–
associated Sec14p affects Kes1p localization. Sec14p stimu-
lates PIP synthesis in a variety of in vitro systems (Hay and
Martin, 1993; Cunningham et al., 1996; Jones et al., 1998).
Moreover, Sec14p stimulates PI(4)P synthesis in yeast
(Hama et al., 1999; Phillips et al., 1999). Kes1p localization
is not compromised in sec14-1
ts strains at 26 C. Shift of the
sec14-1
ts strain to 37 C for 30 min reduces, but does not
abolish, Kes1p association with Golgi membranes (Fig. 7 B).
Localization of Kes1p to Golgi membranes requires a 
functional OSBP domain
Analyses of mutants compromised for OSBP domain func-
tion demonstrate that an intact OSBP domain is also essen-
tial for proper localization of Kes1p-GFP in living cells. Im-
aging experiments show that the Kes1p
K109A-GFP chimera
adopts a diffuse cytosolic distribution with no visible con-
centration in punctate structures (Fig. 7 C). Kes1p-GFP chi-
meras with mutant OSBP domains (i.e., Kes1p
HH143/144AA-
GFP, Kes1p
LG115/116AA-GFP, and Kes1p
VS141/142AA-GFP) also
exhibit exclusively cytosolic staining profiles (unpublished
data). Of interest is the allele specificity that underlies these
localization defects. E107K represents a missense substitu-
tion at a position only two residues upstream of K109A. Yet,
Kes1p
E107K does not mistarget to the cytosol (unpublished
data), whereas Kes1p
K109A does. Finally, mutations that re-
lease Kes1p-GFP to the cytosol are not limited to the OSBP
domain. For example, LH201/202FN also has this effect
(unpublished data). We conclude the region bounded by
Kes1p residues 109–202 is critical for the Kes1p localization
to membranes, and that the OSBP domain is an essential
component of this membrane targeting information.
Because Kes1ps with defective OSBP domains bind PIPs,
we tested whether this domain contributes to Golgi region
targeting by binding another lipid. To this end, we deter-
mined whether the phospholipase D (PLD)-driven accumu-
lation of PA that accompanies Sec14p inactivation is re-
Figure 7. Kes1p targeting to yeast Golgi membranes. (A) Kes1p 
localization domains. YCp(GFP), YCp(KES1-GFP) and mutant 
YCp(kes1
3E-GFP), YCp(kes1
E312K-GFP), YCp(kes1
W317A-GFP), and 
YCp(kes1
K109A-GFP) plasmids were introduced into a kes1 yeast 
strain. Fluorescence images were captured at 26 C. The kes1p
3E-GFP 
and chimeras exhibit a diffuse cytosolic distribution that mimics that 
of GFP alone. In these three cases, signal is excluded from vacuoles 
(the dark circular structures). The wild-type (WT) control Kes1p-GFP 
and the mutant Kes1p
E312K-GFP and Kes1p
W317A-GFP chimeras exhibit 
typical punctate staining patterns. (B) PI(4)P synthesis and Kes1p
localization. A YCp(KES1::GFP) plasmid was introduced into wild-
type, pik1-101
ts, stt4
ts, sec14-1
ts, and mss4-2
ts strains as indicated at 
right. Fluorescence images were captured at 26 C and after shift to 
37 C for 2 h (indicated at top) at an excitation wavelength of 
495nm. Pik1p defects exert major defects in Kes1p localization to 
Golgi membranes, whereas inactivation of Stt4p and Sec14p has 
more modest effects.OSBPs and Sec14p function in yeast | Li et al. 71
quired for Kes1p localization to the yeast Golgi region. This
effort was motivated by the weak binding of Kes1p to PA
monomers (see above). PLD deficiency markedly reduces
Golgi region/endosomal PA levels in Sec14p-deficient yeast
(Li et al., 2000a), but has no effect on Kes1p localization in
Sec14p-deficient strains (unpublished data). In accord with
our previous findings that the involvement of Kes1p in yeast
Golgi region function is independent of metabolic flux
through the yeast sterol biosynthetic pathway (Fang et al.,
1996), we also find that mutations compromising sterol bio-
synthesis (e.g., erg6) do not result in obvious mislocalization
of Kes1p from Golgi membranes (unpublished data).
Relationship between magnitude of Kes1p 
overexpression required for compromise of “bypass 
Sec14p” and PI(4)P levels
Since genetic data indicate Kes1p antagonizes activity of the
Sec14p pathway for Golgi region secretory function, we
overexpressed Kes1p in “bypass Sec14p” mutant strains. In
agreement with previous demonstrations (Fang et al., 1996),
all mechanisms for “bypass Sec14p” are sensitive to increased
KES1 gene dosage (Fig. 8 A). Kes1p is unique in this respect.
Increased dosage of structural genes for enzymes of the CDP-
choline pathway (i.e., CKI1, PCT1, and CPT1) or the Sac1p
PIP phosphatase (SAC1) have no effect on nonallelic mecha-
nisms for “bypass Sec14p” (unpublished data). Although
modest overproduction of Kes1p compromises all other
mechanisms of “bypass Sec14p”, robust overexpression of
Kes1p is required for this effect in sac1 mutants (Fig. 8 A).
Because sac1 mutants are unique among “bypass Sec14p”
mutants in their massive overproduction of PI(4)P (Guo et
al., 1999; Rivas et al., 1999; Stock et al., 1999), there is a
correlation between PI(4)P levels and the magnitude of
Kes1p overproduction required to abolish “bypass Sec14p”.
To investigate whether the Kes1p levels required to abolish
“bypass Sec14p” in sac1 mutants are proportional to PI(4)P
Figure 8. Kes1p dosage and “bypass Sec14p”. (A) Distinct sensitivities of different mechanisms for “bypass Sec14p” to increased Kes1p 
dosages. Kes1p was modestly overexpressed by introduction of YCp (KES1), or highly overexpressed by introduction of YEp(PPGK:: KES1), 
which drives Kes1p expression from a powerful PGK promoter (see Materials and methods). All mechanisms of “bypass Sec14p” except that 
mediated by sac1 are sensitive to modest increases (two- to threefold) in Kes1p levels. A high degree ( 20-fold) of Kes1p is required for 
compromise of “bypass Sec14p” in sac1 mutants. (B) Structure of Sac1p TM. The first 462 codons of Sac1p, which include the catalytic 
domain but not the transmembrane domain, were fused to a protein A tag. This construct is designated Sac1p TM and its expression is under 
control of the native SAC1 promoter. Details of the construction are available from the authors by request. (C) PI(4)P levels as a function of 
Sac1p TM expression. A wild-type SAC1 strain, a sac1 mutant strain, and isogenic sac1 derivatives transformed either with YCp(sac1
 TM) or 
YEp(sac1
 TM) were pulse radiolabeled for 20 min at 26 C with [
32P]-orthophosphate (10  Ci/ml), phospholipids were extracted under acidic 
conditions, lipids were resolved by two-dimensional paper chromatography, and PI(4)P was identified and quantified by phosphorimaging 
(Rivas et al., 1999). PI(4)P is expressed as a percentage of total extractable phospholipid. Relevant strain genotypes are indicated. The various 
strains incorporated similar amounts of [
32P]-radiolabel into total lipid. Data are expressed as the mean   standard deviation from at least three 
independent experiments. (D) Sac1p TM expression sensitizes sac1-mediated “bypass Sec14p” to Kes1p. Isogenic sac1 and sac1/YEp(sac1
 TM) 
yeast strains were transformed with YCp(KES1). Transformants were subsequently isolated and streaked for isolated colonies on selective 
medium at 37 C. Growth was scored after 48 h of incubation. Relevant genotypes are given.72 The Journal of Cell Biology | Volume 157, Number 1, 2002
levels, we expressed in sac1 mutants a truncated Sac1p. This
truncated Sac1p TM contains the PIP phosphatase cata-
lytic domain but lacks the COOH-terminal transmembrane
domain (Fig. 8 B). Sac1p TM is a partially functional pro-
tein as it partially alleviates the derangement of PIP metabo-
lism that characterizes sac1 mutants (Fig. 8 C). As shown
previously, PI(4)P constitutes 17.8   0.8% and 3.6   0.6%
of extractable phospholipid in sac1 mutants and wild-type
yeast, respectively (Guo et al., 1999; Rivas et al., 1999;
Stock et al., 1999). By comparison, PI(4)P levels are mark-
edly reduced to 8.1   1.2% in the sac1 mutant that ex-
presses Sac1p TM from YEp(sac1
 TM) (Fig. 8 C). Expres-
sion of Sac1p TM from a YCp(sac1
 TM) vector effects only
minor reductions in PI(4)P levels in a sac1 genetic back-
ground (15.3   0.5%).
The reduction in PI(4)P recorded in the YEp(sac1 
TM)
strain corrects the inositol auxotrophy and cs growth
phenotypes of sac1 mutants, but fails to ablate sac1-
mediated “bypass Sec14p” (unpublished data). However,
Sac1p TM-mediated reduction in PI(4)P levels strongly
sensitizes the “bypass Sec14p” phenotype of sac1 mutants
to elevated Kes1p. Whereas large increases in KES1 dosage
are required for compromise of “bypass Sec14p” in sac1
mutants, modest increases in KES1 dosage ablate “bypass
Sec14p” in sac1 YEp(sac1 
TM) strains (Fig. 8 D). Thus,
the magnitude of Kes1p overproduction required for
compromise of “bypass Sec14p” is proportional to cellular
PI(4)P levels.
Kes1p is mislocalized in sac1 mutants
Based on analyses of PI(4)P levels in sac1 mutants bearing
pik1
ts and stt4
ts mutations, it is clear that the accumulated
PI(4)P is predominantly synthesized via the Stt4p PI 4-kinase
and not the Pik1p kinase (Nemoto et al., 2000; Foti et al.,
2001). Because Pik1p is the Golgi region–localized PI 4-kinase
(Walch-Solimena and Novick, 1999) and PI(4)P is likely the
physiological ligand for Kes1p, we assessed the localization of
Kes1p-GFP in sac1 mutants. As shown in Fig. 9 A, the intra-
cellular profile of Kes1p-GFP distribution in sac1 mutants is
dramatically different from its normal punctate distribution
in wild-type strains. Rather, Kes1p-GFP localizes to a few
large patches in sac1 cells that are frequently located in a juxta-
nuclear position. This altered Kes1p localization pattern does
not reflect abnormal sac1 Golgi region morphology. Distribu-
tion of the Golgi complex marker Kex2p is not altered in sac1
mutants (Fig. 9 B). Rather, consistent with the significant (if
not exclusive) localization of a Sac1p to ER compartments in
yeast and mammalian cells (Whitters et al., 1993; Nemoto et
al., 2000; Foti et al., 2001), we conclude that Kes1p is mistar-
geted to what are likely ER membranes in sac1 mutants. We
suggest that Kes1p is mistargeted to ER membrane domains
enriched in the PI(4)P that accumulates in these mutants. In
support of this idea, the Kes1p PH domain is required for this
mislocalization as Kes1p
3E-GFP retains its cytosolic localiza-
tion in sac1 mutants, and fusion of the Sac1p PIP phosphatase
catalytic domain to the ER-resident protein Sec61p yields a
fully functional Sac1p whose expression complements all
Figure 9. Kes1p mislocalization in sac1 mutants. YCp(KES1-GFP) 
and YEp(KEX2-RFP) plasmids were transformed into wild-type or 
isogenic sac1 yeast. Liquid cultures of the plasmid-bearing derivatives 
were incubated at 26 C in the appropriate minimal medium. Cells 
were mounted and visualized by fluorescence microscopy. Kes1p-
GFP and Kex2p-RFP profiles are shown in A and B, respectively. 
Relevant genotypes are indicated at left. Because Kex2p is an
integral membrane protein, Nomarski images are shown below the 
corresponding fluorescence images in B.OSBPs and Sec14p function in yeast | Li et al. 73
sac1  phenotypes (including the “bypass Sec14p” phenotype
[unpublished data]).
Genetic interactions of kes1  with arf1 , gcs1 , 
and pik1-101
ts
To further understand how Kes1p functions in yeast, we
screened for instructive genetic interactions. The phenotypes
associated with Kes1p overproduction in many ways mimic
those associated with reduced PLD activity (Xie et al.,
1998), suggesting that Kes1p is an inhibitor of PLD in yeast.
However, our in vivo experiments indicate PLD activity is
not sensitive to high levels of Kes1p (unpublished data).
Rather, we observed a linkage between Kes1p function and
the yeast ARF cycle. Both arf1  and gcs1  alleles abrogate
kes1 -mediated “bypass Sec14p”. Although an sec14-1
ts mu-
tant cannot grow at 37 C, the sec14-1
ts kes1  derivative
grows at wild-type rates. However, the isogenic sec14-1
ts
kes1  arf1  and sec14-1
ts kes1  gcs1  triple mutants are no
longer viable at 37 C (Fig. 10 A). This is not the result of
more complex genetic interactions between kes1  and arf1 
or  gcs1  as introduction of SEC14 into sec14-1
ts kes1 
arf1  and sec14-1
ts kes1  gcs1  mutants restores viability at
37 C (unpublished data). Gcs1p is an ARFGAP, and it is
this biochemical activity that is required for kes1-mediated
“bypass Sec14p” (Yanagisawa, L., and V.A. Bankaitus, un-
published data).
Second, we recorded a genetic interaction between kes1 
and a mutation that compromises activity of the Pik1p PI
4-kinase. Yeast strains carrying pik1-101
ts grow at 26 C, but
not at 35 C or 37 C (Walch-Solimena and Novick, 1999;
Fig. 10 B). A kes1  allele clearly improves the growth of
pik1-101
ts strains at 35 C. In a serial dilution array incu-
bated at 35 C, the pik1-101
ts mutant forms colonies only in
the undiluted culture inoculum. By contrast, the wild-type
control exhibits growth in undiluted and low dilution in-
nocula; i.e., single colonies are scored in regions spotted with
aliquots of 1,000-fold dilutions of culture sample. Thus, rel-
ative to wild-type, there is an  1,000-fold reduction in the
viability of pik1-101
ts mutants cultured at 35 C. The kes1 
pik1-101
ts mutant exhibits a growth profile intermediate be-
tween those of wild-type and pik1-101
ts strains (Fig. 10 B).
Growth was recorded in the inoculum of a 10-fold culture
dilution. Thus, kes1  increases the viability of pik1-101
ts
mutants some 10-fold at 35 C. This effect is not observed at
37 C, indicating kes1  exerts only partial suppression of
pik1-101
ts defects (unpublished data). Nonetheless, this ef-
fect is specific by two criteria. First, kes1  allele has no bene-
ficial effect on the growth of yeast strains defective in Stt4p
(unpublished data). Second, no other “bypass Sec14p” al-
leles (including sac1 alleles) suppress pik1-101
ts–associated
growth or secretory defects at 35 C (unpublished data).
Genetic interactions of kes1  with ARF 
and ARFGAP deficiencies
Kes1p deficiency elicits a “bypass Sec14p” that, like all “by-
pass Sec14p” phenotypes, requires Gcs1p ARFGAP activity
(Yanagisawa, L., and V.A. Bankaitus, unpublished data).
Our finding that Kes1p overproduction mimics Gcs1p de-
fects in “bypass Sec14p” mutants further supports the possi-
bility that Kes1p influences regulation of the ARF cycle.
Therefore, we tested whether kes1  suppresses phenotypes as-
sociated with Gcs1p or ARF dysfunction.
Sodium fluoride (NaF) sensitivity is associated with defects
in the yeast ARF cycle (Zhang et al., 1998). Gcs1p-deficient
mutants are sensitive to NaF, as are arf2  strains carrying the
arf1-3
ts mutation (Zhang et al., 1998; Table I). Based on the
results described above, we predicted that Kes1p defects might
suppress NaF sensitivity in gcs1  and arf1-3 arf2  strains. Al-
though both gcs1  and arf1-3 arf2  mutants fail to grow in
the presence of 30 and 50 mM NaF, isogenic wild-type strains
are NaF resistant (Table I). However, kes1  suppresses Gcs1p
and ARF1p deficiency in this assay as isogenic kes1  gcs1 
and kes1  arf1-3 arf2  mutants grow when challenged with
either 30 or 50 mM NaF (Table I). Serial dilution experi-
ments indicate that the viability of gcs1  strains is increased
 1,000-fold relative by kes1 .
This is not a trivial result of Kes1p defects reducing either
the permeability of cells to NaF or the capacity of yeast to
accumulate NaF as kes1  does not increase the threshold of
yeast tolerance to NaF. Moreover, kes1  only modestly in-
fluences other phenotypes associated with Gcs1p defects
(e.g., sensitivity to hyperosmotic stress). The viability of
gcs1  mutants is reduced  10-fold relative to that of
isogenic gcs1  kes1  mutants (unpublished data). Zhang et
al. (1998) reported that overproduction of any one of several
ARFGAPs, including Gcs1p, suppresses NaF sensitivity in
arf1-3 arf2  yeast strains. Thus, kes1  phenocopies the ele-
vation of ARFGAP levels in arf1-3 arf2  yeast mutants. Fi-
nally, we note that the pik1-101
ts mutant resembles gcs1 
and arf1-3
ts strains in its NaF sensitive growth, and that NaF
sensitivity is relieved by kes1  (Table I).
Discussion
Herein, we show Kes1p binds PIPs and this PIP-binding
property, in conjunction with its conserved OSBP domain,
is essential for Kes1p localization to Golgi membranes. The
PIP pool required for Kes1p targeting to Golgi membranes
is driven by activity of the Pik1p PI 4-kinase, and Golgi re-
gion targeting of Kes1p is required for inhibition of Sec14p-
dependent Golgi region function in vivo. We further dem-
onstrate that inactivation of Kes1p not only affects “bypass
Sec14p”, but that it also elicits a suppression of some pheno-
types associated with ARF and ARFGAP dysfunction. We
propose that it is through its effects on ARF that Kes1p reg-
ulates Sec14p-dependent Golgi membrane secretory func-
tion in yeast.
The PIP binding activity resides in what appears to be a
Kes1p PH domain. Although the existence of PH domains
has been documented for long OSBPs (e.g., OXYB yeast
Osh1; Levine and Munro, 1998), our findings represent the
first demonstration that short OSBPs also binds PIPs. More-
over, our data demonstrate that PIP binding, and its role in
targeting an OSBP to Golgi membranes, is a functionally
important activity in cells. With regard to the binding of
Kes1p to other lipids, we failed to detect significant binding
of Kes1p to 25-hydroxycholesterol (unpublished data).
One unanticipated result obtained from analysis of muta-
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and W317A mutations abolish PIP binding in the context of
full-length Kes1p, but not when the COOH-terminal 120
Kes1p residues are removed. Thus, E312K and W317A do not
affect PIP binding directly. Rather, these substitutions likely
affect Kes1p conformation in such a way that the PH do-
main is not accessible to PIPs. Consistent with this model,
E312 and W317 do not reside in the predicted PIP binding
loops of the Kes1p PH domain, and truncation of the Kes1p
COOH terminus does not rescue PIP binding defects asso-
ciated with mutations in those loops. Because removal of the
Kes1p COOH terminus suppresses E312K- and W317A-asso-
ciated PIP binding defects, we speculate that the Kes1p
COOH terminus interferes with PH domain function by
occluding the PIP binding site. This proposal suggests that
PIP binding by Kes1p is subject to conformational regula-
tion by posttranslational modification, or by interaction of
Kes1p with some other binding partner (either protein or
lipid). This concept is supported by our demonstration that
the E312K and W317A substitutions do not abrogate Kes1p
targeting to the Golgi complex in vivo, whereas intrinsic
Kes1p defects in PIP binding and defects in PIP synthesis by
the Pik1p PI-kinase do.
Unlike the case for long OSBPs, PIP binding is insufficient
for Kes1p targeting to Golgi membranes. An intact OSBP do-
main is also required. These data provide the first indication of
a function for this signature motif of OSBPs. It remains unclear
how the OSBP domain is involved in localization of Kes1p to
Golgi membranes. One possibility is that the Kes1p OSBP mo-
tif interacts with the Kes1p COOH terminus to expose the PH
domain for PIP binding. We do not find compelling evidence
in favor of this model. Inactivating mutations in the OSBP do-
main neither abolish PIP binding by Kes1p, nor do these
strongly compromise the affinity of Kes1p binding of PIP
monomers in a mixed micelle system. Alternatively, the
OSBP domain may increase the avidity of Kes1p for Golgi
membranes by binding another Golgi complex–localized
ligand. Finally, the OSBP domain may represent an inter-
face for homotypic binding of Kes1p molecules to each
other so that the PH domains are configured in a dimeric ar-
rangement where the PIP binding loops of each PH domain
unit are exposed on one face of the dimer. This would gener-
ate a PIP binding module with a higher affinity for PIP than
that exhibited by monomeric Kes1p. However, an increased
binding affinity of dimeric Kes1p would not be apparent in
the mixed micelle system we have employed to measure
Kes1p–PIP interaction.
Although Kes1p plays an important role in Golgi function
in yeast (Fang et al., 1996), the in vivo functions of OSBPs
Figure 10. Genetic interactions between kes1 , arf1 , gcs1 , 
and pik1–101
ts alleles. (A) “Bypass Sec14p” in arf1  strains. 
Isogenic sets of wild-type (WT), sec14-1
ts, sec14-1
ts kes1 , sec14-1
ts 
kes1  arf1 , and sec14-1
ts kes1  gcs1  strains were incubated on 
YPD agar at 26 C or 37 C (a restrictive temperature for sec14-1
ts 
strains) as indicated for 72 h. WT and sec14-1
ts strains represent 
positive and negative growth controls, respectively. The kes1  
allele rescues sec14-1
ts lethality at 37 C, and this rescue is abolished 
by arf1  and gcs1 . The arf1  and gcs1  alleles do not compromise 
growth of otherwise WT strains at 37 C. (B) Kes1p deficiency partially 
suppresses growth defects of the pik1
ts strain. Each strain was serially 
diluted from original culture (OD600   0.6) by 10-, 100-, and 1,000-
fold. 3  l of each dilution was inoculated onto YPD plates, and plates 
were incubated for 3 d at 26 C and 35 C, respectively.
Table I. Interactions of kes1 mutations with perturbations in
Arf function
Genotype NaF (0 mM) NaF (30 mM) NaF (50 mM)
WT            
sec14-1
ts            
arf1-3 arf2        
arf1-3 arf2  kes1         
sec14-1
ts gcs1        
sec14-1
ts gcs1  kes1             
pik1-101
ts        
pik1-101
ts kes1             
Genetic interactions between Kes1p and ARF cycle components. KES1 was
deleted in gcs1D, arf1-3ts arf2D, and in pik1ts mutants, and strains were
grown on YPD agar with indicated NaF concentrations. Wild-type colony
size is indicated by    , smaller colonies by   , and   indicates no
growth at all after 3 d at 26 C. In arf1, gcs1, and pik1 mutants challenged
with 50 mM NaF, kes1D affects 103-fold increases in cell viability.OSBPs and Sec14p function in yeast | Li et al. 75
in eukaryotic cells remain unresolved. We suggest that
Kes1p function somehow interfaces with activity of the yeast
ARF cycle. We find that arf1  and gcs1  both abrogate
kes1 -mediated “bypass Sec14p”, and several other lines of
genetic evidence indicate that Kes1p dysfunction mimics el-
evated ARFGAP function, whereas elevated Kes1p pheno-
copies reduced ARFGAP function. Thus, Kes1p may act as:
(a) an inhibitor of the Gcs1p ARFGAP activity that is re-
quired for yeast Sec14p-dependent Golgi complex function
(Yanagisawa, L., and V.A. Bankaitus, unpublished data), (b)
a novel ARF nucleotide exchange factor, or (c) an activator
of an ARF nucleotide exchange factor. In our hands, Kes1p
fails to inhibit the ARFGAP activity of Gcs1p in vitro and
we have not detected intrinsic ARF nucleotide exchange ac-
tivity associated with Kes1p (unpublished data).
Our data suggest that Kes1p may regulate ARF function
through its effects on PIP synthesis via the Golgi com-
plex–associated Pik1p as evidenced by the demonstration
Kes1p defects partially suppress growth defects associated
with Pik1p dysfunction. Kes1p may function, directly or
indirectly, as a Pik1p inhibitor in vivo. Alternatively, ef-
fects of Kes1p on the ARF cycle may influence Pik1p ac-
tivity. Linkage of Kes1p localization and function to
Pik1p-mediated PI(4)P synthesis suggests that PI(4)P is
the physiological Kes1p ligand. Although PI(4,5)P2 is
bound by Kes1p with a 10-fold higher affinity, PI(4)P
mass is fourfold greater than that of PI(4,5)P2 in yeast.
Moreover, defects in PI(4,5)P2 synthesis do not compro-
mise Kes1p localization to Golgi membranes, and massive
accumulation of PI(4)P in a non-Golgi compartment en-
tices Kes1p from Golgi membranes. The latter result sug-
gests that a component of the mechanism by which sac1-
mediated PI(4)P accumulation contributes to “bypass
Sec14p” is an indirect one that involves Kes1p mistarget-
ing to what is likely the ER. Finally, the data identify
Kes1p as a reporter for Pik1p-driven PIP synthesis on
yeast Golgi membranes. Thus, Pik1p facilitates the para-
doxical recruitment to Golgi membranes of a protein
whose dysfunction permits Sec14p-independent secretory
function of Golgi membranes.
Materials and methods
Strains, media, and reagents
Genotypes for yeast strains are listed in Table II. Media are described else-
where (Sherman et al., 1983), as are E. coli and yeast plasmid transforma-
tion techniques (Ito et al., 1983). Vector pQE30 was from QIAGEN. Hi-
Trap Ni
  chelating columns and glutathione-Sepharose 4B beads were
from Amersham Pharmacia Biotech. PI(4,5)P2, PI(4)P, and IP3 were from
CalBiochem. PI(3,4)P2 and PI(3,5)P2 were from Echelon Research Labora-
tories. Other lipids were from Avanti Polar Lipids, Inc. Fine chemicals
were from Sigma-Aldrich unless specified. Restriction enzymes were pur-
chased from Promega. [ -
35S]-dATP was obtained from Amersham Phar-
macia Biotech.
Recovery of genomic kes1 alleles
An integrative KES1 plasmid (pCTY204) was restricted at a unique site
within the KES1 promoter with AflII. Linearized plasmid was transformed
into kes1 strains and recombinants at the KES1 locus were identified. Ge-
nomic DNA was prepared from transformants, restricted with ClaI, and li-
gated at 15 C. Following transformation into E. coli DH5 , plasmid DNA
was purified and used as template for nucleotide sequencing.
Site-directed mutagenesis
Mutageneses employed QuickChange™ (Stratagene) and confirmed by
DNA sequencing analysis (Sanger et al., 1977) using the Sequenase ver-
sion 2.0 kit (Amersham Pharmacia Biotech).
Plasmid construction
Details of the various plasmid constructions are included in supplemental
materials or are available from the authors by request.
Expression and purification of His6-tagged and GST-tagged 
proteins from E. coli
One liter of Superbroth (12 g tryptone, 24 g yeast extract, 4 g glycerol,
0.17 M KH2PO4, 0.72 M K2HPO4, 50  g/ml ampicillin) was inoculated
with 10 ml of an overnight culture of E. coli strain KK2186 harboring plas-
mids expressing His6- or GST-tagged proteins. Protein production was
induced with isopropyl  -D-thiogalactopyranoside (0.5 mM) and, after
3–5 h, cells were harvested by centrifugation. Cells were disrupted by son-
ication, and Triton X-100 was added (final concentration 0.1% vol/vol).
After addition of DNase I (10  g/ml) and MgCl2 (10 mM), lysate was clari-
fied and filtered.
His6-tagged proteins were purified by HiTrap Ni-chelating column chro-
matography (Amersham Pharmacia Biotech) as per the manufacturer’s in-
structions.
Peptide sequencing
Purified proteins were transferred to Immuno-Blot PVDF membranes (Bio-
Rad Laboratories) using the semidry Transblot apparatus (Bio-Rad Labora-
tories). Blotted PVDF membrane were washed with distilled water and
Table II. Yeast strains and plasmids
Genotypes Source
Strain number
CTY1-1A MATa ura3-52 his3 -200 lys2-801 sec14-1
ts Bankaitis et al., 1989
CTY100 MATa ura3-52 his3 -200 lys2-801 sec14-1
ts sac1-26
cs Cleves et al., 1989
CTY159 MATa ura3-52 his3 -200 lys2-801 sec14-1
ts kes1-1 This study
CTY160 MATa ura3-52 his3 -200 lys2-801 sec14-1
ts cki1-1 Cleves et al., 1989
CTY182 MATa ura3-52 his3 -200 lys2-801 SEC14 Bankaitis et al., 1989
CTY1537 MATa ura3-52 leu2 pik1-101
ts Novick et al., 1980
CTY1585 MATa ura3-52 leu2 pik1-101
ts kes1 ::URA3 This study
Plasmid number
pCTY204 YIp (KES1)
pCTY244 YCp (KES1)
pCTY574 YCp (KES1-GFP)
YEp (KEX2-RFP)
pRE540 His6-KES1
pRE682 GST-KES1
pRE657 GST-KES1(1–314)
pRE665 GST-GST-PH domain76 The Journal of Cell Biology | Volume 157, Number 1, 2002
stained with Ponceau S. Kes1p species were excised from membranes and
subjected to automated NH2-terminal Edman degradation.
Mass spectrometry
MALDI-TOF mass spectrometry was performed using positive mode on a
Voyager Elite unit with delayed extraction technology (PerSeptive Biosys-
tems). Samples were diluted 1:10 with matrix, and 1  l of the resulting mix
was deposited onto a smooth plate. Acceleration voltage was set at 25 kV
and 10–50 laser shots were summed. Sinapinic acid (D13, 460-0; Sigma-
Aldrich) dissolved in acetonitrile: 0.1% TFA (1:1) was used as matrix. The
mass spectrometer was calibrated with bovine serum albumin.
Online supplemental materials
PIP photolabeling assay. Photolabeling and displacement assays were per-
formed as described previously (Kearns et al., 1998b). Details are available
at http://www.jcb.org/cgi/content/full/jcb.200201037/DC1 or from the au-
thors by request.
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